Delivered-To: pgepnewsletter@gmail.com
Received: by 2002:a98:c004:0:b0:1eb:e128:bbe3 with SMTP id l4csp4037247eic;
        Mon, 15 Jan 2024 17:58:14 -0800 (PST)
X-Google-Smtp-Source: AGHT+IF/fKPXYFyMGsXBXKh5R6NoNpquGaRvRa23KDeTGk3piKtX3HE+rDjkv6/sHTpUBDnSR+g3
X-Received: by 2002:a05:622a:44:b0:429:fa8f:c00f with SMTP id y4-20020a05622a004400b00429fa8fc00fmr1973339qtw.63.1705370294071;
        Mon, 15 Jan 2024 17:58:14 -0800 (PST)
ARC-Seal: i=1; a=rsa-sha256; t=1705370294; cv=none;
        d=google.com; s=arc-20160816;
        b=V/vyzgOiLt3lIwyynWbMYeReNuOPWg107KPqcq7Pgu6hhCXYAaUbfmvyeICUUFwPTx
         JWQl30RE2MNlHMEVDMRiPI5G1nRsSllQJb63fXFw8mqSjCplW17LHwDCgji/zrbnCWVd
         KSm2UGZoJweJ5DOgKTK5x0L3YehErmvQ/levZMYoILaWWTXXOqFffzmqODj58/0SIh3i
         wk0WXKXnas9gXC32L6Gi+tV0QzHe6DuU8bn5OSZOBQU1sUJLLmfktGtZzP7PBPeAX8S9
         4DR/ghA0Hj87zBHTFclNbzIGYRu+27MFSQDFebqUdAYwsYiP5DxDTuUA0UbDdhmymCX8
         SCKQ==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=list-unsubscribe:to:reply-to:subject:message-id:mime-version:from
         :date:dkim-signature:dkim-signature;
        bh=nYAxfs8QEXguCF3U8+8xiafTnNtn8aoMGPO4JaqwFjM=;
        fh=m8+yFGL9AGrkSifADXzxzWHypeMVd9MF7/kbikeN2H4=;
        b=VjAFDHVlragyVuo27n7doVijA3RaevD2UZkBd5U9yipcxJYPcjjsgxJR+C+xwAxQ4c
         lcSgaFya2VJ/3MbR34ne+EJXLFb/TrMM5+e23xzyVjnd/JO+JJeRjPSdNFkSjVcXnI3P
         IzHZsgP76AczztHb2S24DMSFKE6E4YM1Dr6TMVaOBYdI6o0a9l9TaOJ+ytzdg9L5wULD
         S2SY2uBXEE1y92ZooBlHbaD+iyEWvsAp3GjGDIq4GT3s6XfbgnUMz2tqW57umEIfCGwK
         S+CKxa3tYgrfdr9E/2RpNchw6LE6UK+7Cl7x1QcVaN2C9ezIRFSw+4mKTF1lcv20IfwZ
         bXGA==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=j67eBwF7;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=UWRh8JTz;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
Return-Path: <bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org>
Received: from xtrwrkzn.outbound-mail.sendgrid.net (xtrwrkzn.outbound-mail.sendgrid.net. [167.89.81.226])
        by mx.google.com with ESMTPS id d14-20020ac85ace000000b004298cd99df9si9012363qtd.290.2024.01.15.17.58.13
        for <pgepnewsletter@gmail.com>
        (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128);
        Mon, 15 Jan 2024 17:58:14 -0800 (PST)
Received-SPF: pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) client-ip=167.89.81.226;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=j67eBwF7;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=UWRh8JTz;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=isid.org;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=s1; bh=nYAxfs8QEXguCF3U8+8xiafTnNtn8aoMGPO4JaqwFjM=;
	b=j67eBwF7P5vDm0Mn61EFK2UWHftGE9wd+9TgMeEjSa9jRxYjtt61WCPH++4eI35dKlTZ
	V1P5AdMRnAh1a25pC4aBrnRuXTAfj314GWWPl0XUDb2EZjrydJZ5bNLgXo1U0uz6XsEnzU
	YW4ImN5jQ9tLfA07puBlgHbVJyesZ3jIpoj8D5btjzUjMKLEs7QsmRKBfz2VvizXK1C/rj
	FCxwh2bBmiMa2URj/yPbpkA3IcySXIh/EkWdeT16GRvB5PlKoMOsrpj0u0Jltr/7eFAMjY
	kKDTeLbJgQTbgqT7oRZ5x7nCU++ufnqggpu1Uax07O0FqMEFnS21CWpz7GZhWuoQ==
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=sendgrid.info;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=smtpapi; bh=nYAxfs8QEXguCF3U8+8xiafTnNtn8aoMGPO4JaqwFjM=;
	b=UWRh8JTzqy5NLIubeeZFPy6yiwDG4vZ98Oy5G8xsxszalE9I6G5a0S6GNo+gnqL9j6iq
	cW2UUaLlzUZyHU1h9ohRNp2FgRMVYMcpA6Ig4KQHDUFjdDZ2nVegCr5riIU2Ix9Fc9lZ1q
	kHW62myg6ercRLpvb6WVx11MGUWOOpf2c=
Received: by filterdrecv-559468bd77-nxzrg with SMTP id filterdrecv-559468bd77-nxzrg-1-65A5E2B4-7
        2024-01-16 01:58:12.397762051 +0000 UTC m=+7802300.961484501
Received: from MTkyNjg2NjI (unknown)
	by geopod-ismtpd-1 (SG) with HTTP
	id FPE1jHIEQIq4xN8wLpDskg
	Tue, 16 Jan 2024 01:58:12.190 +0000 (UTC)
Content-Type: multipart/alternative; boundary=7580712b779411cfa2cab9ba516098e8cc63612d7a780e79fdb083b92193
Date: Tue, 16 Jan 2024 01:58:12 +0000 (UTC)
From: ProMED <promed@isid.org>
Mime-Version: 1.0
Message-ID: <FPE1jHIEQIq4xN8wLpDskg@geopod-ismtpd-1>
Subject: PRO/AH/EDR> Mpox update (03): Nigeria, atypical cases, 2022
Reply-To: noreply@isid.org
X-Feedback-ID: 19268662:SG
X-SG-EID: 
 =?us-ascii?Q?lYKUi1ucKQwcfoVB1xAcbBSlsJP9QSi7ed2VWI0p5NjpCc5BQK+kujBGGO1mU1?=
 =?us-ascii?Q?iBr0jkvLTO3tGC0UD0m22MZel1UIOTL4nseU8OL?=
 =?us-ascii?Q?o7pH+TEzKetVU9pZc6MIwKaq+9m2LLljCu6iHEC?=
 =?us-ascii?Q?hNS8oPXM6uJntbB+JeJ9Jv05iFFb1L69bCEnnTs?=
 =?us-ascii?Q?+gPjBaQJKPbWwoBH98MBuBTnLZCi1PeGuwK+UnU?=
 =?us-ascii?Q?DeD1Vk263cUZ0sWQpCxO1onNE74TM=2FtXYeokJ3?=
X-SG-ID: 
 =?us-ascii?Q?se=2F49CGmbS0sfR97ImeXvNhg9p9jggtUUChgqoY2wUiShGf=2FO8XJWpH34Od4Nd?=
 =?us-ascii?Q?fxXa6jil96uRcJkF+N+LeVnO1tx80ddOyoyOo=2Fc?=
 =?us-ascii?Q?Brxcl3ERAm0cOY743=2FFH59DWiSf5OzXORh1DLKt?=
 =?us-ascii?Q?hb1NMKty3PsA5ju0ZzxCrq1WQuZSEQf=2FJlWtgqv?=
 =?us-ascii?Q?cZmsyCHlNUZsDwOAAIJqzLsrUJEJdMMtEs+ugWe?=
 =?us-ascii?Q?VzekCHQF+ZPdkfrz5Hd7F01VWqpkQ1VD7nYq7SX?=
 =?us-ascii?Q?kuhC+Nni2jE4HuvSZz+ysJbfl+3kCIwfOZ9vH3D?=
 =?us-ascii?Q?1sH7MjSMxxxQZCOYWKdKR2GIN8mdYWETi2nDrZ7?=
 =?us-ascii?Q?XymjP053SWLkbGjXFoSImyzqZWuUQ3besomM5ou?=
 =?us-ascii?Q?TpJyx5pDU1pgGFz5TOvFX0YbAKsWpOFUC0SowjH?=
 =?us-ascii?Q?KstHMKYG6tRLW=2FKusFfUjkdUASz5JMPwlr9MHs2?=
 =?us-ascii?Q?D2bdEYpuZQHndB8x3B8CiFEXW5JSFNVLk7A+Zyu?=
 =?us-ascii?Q?T1pMtnZDsYk6xmrO5MEy8IXW0PXD05Dg46fUEvJ?=
 =?us-ascii?Q?=2Fazd8RnqmYpy=2F+TJeQZuOCSKla60WnWOHwRIQSb?=
 =?us-ascii?Q?dlau9=2F00ySt7u3y6upPYVmFNz+CO4S5gkV34OCV?=
 =?us-ascii?Q?Fni4r=2FZspuh8bgPoSY6WWb9=2FNAzLVatsg9By2TW?=
 =?us-ascii?Q?DXnzozv7wC8Mkrb2FdibeS1WvE0dA82q3WbQ6mn?=
 =?us-ascii?Q?ZnrCC12apKonB48Fuz+=2Fllj3J=2FVNNfCw1k=2Fh6Jf?=
 =?us-ascii?Q?bTeZJ5SvUOunWMJbcjyZltkREYAqEByv+w=2FF9uS?=
 =?us-ascii?Q?8AdfqOKmFC4hPlIMXMftqXOr8g=3D=3D?=
To: pgepnewsletter@gmail.com
X-Entity-ID: 3CKJgmVGbBVD214dsRqreg==
List-Unsubscribe: 
 =?us-ascii?Q?=3Cmailto=3Aunsubscribe=40em7004=2Eisid=2Eorg=3Fsubject=3D19268662=2EOdPd0AXKU?=
 =?us-ascii?Q?OGMhqvMfCIxufAgOH1bw5FFfMiaW-8qmj1oMDAw?=
 =?us-ascii?Q?dTAwMAcU4mqG8EphgKwb0HOxmVLwOYkp4L7dnR3?=
 =?us-ascii?Q?yC9c-CcYQZdVg=5Fe8W967nw7yU4v5mHYh4z8Y7D5?=
 =?us-ascii?Q?W53zS-kxU0lkIp6TEx0HDKalshXBAYP21rOWmSD?=
 =?us-ascii?Q?1Mm7w0NEkxK2=5F67GQ=3D=3D=2EdpwdUfDJu0qzOHGxd3c?=
 =?us-ascii?Q?FCfMICSqsYNnvHysK46UVFIloMDAwdTAwMJmVfY?=
 =?us-ascii?Q?XdmFzUDC47P5WXjoQtONhV=5FN1KrtTWyv12Xv5dh?=
 =?us-ascii?Q?8HENuHTMXAC9ODZQaqYx2kNVJjWIuZKMR=5F7oHnG?=
 =?us-ascii?Q?2LWw7dtOB7Uvpyvo2YXpSdlvYOmMTjxsMUiqY4x?=
 =?us-ascii?Q?DO4lt774IRREXhIepIxUGxyWqwnz8cjXon5shog?=
 =?us-ascii?Q?k=5FZOeSX8A485cvq0AORUqOMdEyIi83em1mGDMMB?=
 =?us-ascii?Q?c-nTUBOcLa4HJk-jrVkhcQJu32sfPMV8TSROZ-U?=
 =?us-ascii?Q?-EBdfECFJgzOHju=5FHmGXl3nQEc=5FP16cd1NDAyp6?=
 =?us-ascii?Q?nAf0eSWpL55=5FN5DZ5pF5nzKWK8lQTb59XsIiFOd?=
 =?us-ascii?Q?65sp4zOofHECD0U9BFAUEo=5FgSFwWamxNz7k1kO6?=
 =?us-ascii?Q?tcUcznUIckYL=5FvKavYLeeTJJb8x78rK1UJpMJyH?=
 =?us-ascii?Q?f2z=5Fmi5xJQ0IPY7mjnF6YuyxdRDInY-5nilQVIt?=
 =?us-ascii?Q?Yh8ZcF0WfMOgflyX=5FCerzegqohsbFWMKe-XV0P0?=
 =?us-ascii?Q?RmXEiCi8nFGQYaV5QkG7RO1wiyAShgyST0nDBw6?=
 =?us-ascii?Q?7OFo3YvzK-O31O4W6QPzOJu9LPXhDq3QPReXuXe?=
 =?us-ascii?Q?P3whwkWmsSa8y-Pl8N-Ue-Vq3e4lzTdO4R2EPIv?=
 =?us-ascii?Q?ENV6n5nuI65GHAT1qcmghvCIwluF1=5F2FIR4NDX0?=
 =?us-ascii?Q?8jiXORTD4jxB8AXrjpi8uMkCYiniUO293Sz0DF4?=
 =?us-ascii?Q?6KFlKbPpCDKojDAHyAZ02ebtQoPruek5N7t=5FJAI?=
 =?us-ascii?Q?33lF89zG5jdQLYSh33j88wNrpAmG8ysybIjUxKi?=
 =?us-ascii?Q?Vw=5Fh3o2kfecu0b5zMJeWQS=5F-8hi2A4FbcA6V4bR?=
 =?us-ascii?Q?Lt5nVPrPAq2VrotMMIaQNkdMY4yHuHOsziqafvr?=
 =?us-ascii?Q?NhRdfDXuV6gUwfGG03I6ZtMUSZK5If76XVW4QdH?=
 =?us-ascii?Q?WIZ-YNjjwwCYwVfB0NbPPr8cbmTi0ICBE-beRel?=
 =?us-ascii?Q?0gSFLrXWxn0j=5FtC2MS8yW0kDVe6Dbd0SiZfoySN?=
 =?us-ascii?Q?iyW0D5rLe2dIdpI=5FE=5Fn51=5FskZHSeGe0vQaWRRXK?=
 =?us-ascii?Q?McaSereskMLEa3QhVof7nuL9dMDmC1WXd4l4bzq?=
 =?us-ascii?Q?Qd8PUw=3D=3D=3E?=

--7580712b779411cfa2cab9ba516098e8cc63612d7a780e79fdb083b92193
Content-Transfer-Encoding: quoted-printable
Content-Type: text/plain; charset=us-ascii
Mime-Version: 1.0

MPOX UPDATE (03): NIGERIA, ATYPICAL CASES, 2022
***********************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Sat 13 Jan 2024
Source: Healio [edited]
<https://www.healio.com/news/infectious-disease/20240112/2022-mpox-outbreak=
-cases-had-atypical-symptoms-and-presentation>


During a 2022 mpox outbreak in a Nigerian tertiary care facility,
several confirmed cases presented atypically, according to a recent
assessment of cases.

"Having managed cases of mpox previously, I became amazed at the
gradual drift of the clinical presentation from the usual, previously
documented, and observed pattern of presentation to some forms I
considered atypical," Nneka M. Chika-Igwenyi, MD, an infectious
diseases physician at Alex Ekwueme Federal University Teaching
Hospital, Abakaliki, told Healio. "This spored me into highlighting
some of the observed atypical presentations."

During a 2022 mpox outbreak in a Nigerian facility, cases deviated
from the typical presentation highlighting the need for further
evaluation of unusual skin lesions and increased mpox screening.
Chika-Igwenyi and colleagues assessed clinical and epidemiological
data of PCR-confirmed mpox cases reported during the 2022 outbreak to
gather information on unusual presentations.

Of 17 suspected cases reported during the outbreak, 13 were PCR
confirmed. Among these 13 patients, there were several atypical
presentations.

According to Chika-Igwenyi, these cases occurred among young adults
and were more common in males (64.3%), which is in contrast to
previously documented occurrence in children and young females.
Additionally, among these patients, there was a lack of prodromal
symptoms (reported among only 3 or 23.1% of cases) that usually
indicate the onset of skin lesions. When patients did have prodromal
symptoms, symptoms persisted for longer than a week in 38.5% of
cases.

All 13 patients experienced rash of "various distribution." Skin
lesions were polymorphic in 6 cases (46.2%) with solitary skin lesions
reported in 3 patients (23.1%). Chika-Igwenyi added that contrary to
previous outbreaks where skin lesions followed typical stages and were
synchronous, some cases had asynchronous lesions with rashes occurring
at different stages of development. According to the study,
significant genital lesions were reported in both genders and in 6
(46.2%) cases. Perianal lesions were also reported atypically among
heterosexuals and non-men who have sex with men population patients
(71.1%) with one case (7.7%) being severe.

Based on these assessments, Chika-Igwenyi said that moving forward
there needs to be screening and evaluation of genital skin lesions
presumed to be sexually transmitted infections. There should also be a
revision of clinical case definition to include the reported atypical
presentations.

"[There should be a] high index of suspicion among clinicians and
public health interventions using a one-health approach,"
Chika-Igwenyi concluded.

[Byline: Caitlyn Stulpin]

--
Communicated by:
ProMED

[This case report highlights the need for further inclusion of mpox in
clinician differentials for patients with any genital lesion
regardless of sex or sexuality. As we have seen throughout mpox
outbreaks, case presentation can be extremely variable with symptoms
typically residing on their own. This should raise concern as to
whether patients are actually receiving the appropriate diagnosis or
if the virus is simply running its course. The prodromal phase they
present with also means that patients could be contagious for an
extended period without rash symptoms, leading to further spread of
the virus. - Mod.CS

ProMED map:
Nigeria: <https://promedmail.org/promed-post?place=3D8714253,62>]

[See Also:
Mpox update (02): Israel, new cases, MOH
http://promedmail.org/post/20240111.8714172
Mpox update (01): Cambodia, new cases
http://promedmail.org/post/20240105.8714076
2023
----
Mpox update (51): Cambodia (PP) local case
http://promedmail.org/post/20231214.8713728
Mpox update (50): Viet Nam (Mekong Delta region)
http://promedmail.org/post/20231208.8713590
Mpox update (49): WHO, Congo DR, USA (ID), Indonesia
http://promedmail.org/post/20231127.8713353
Mpox update (48): Viet Nam, Taiwan, Indonesia
http://promedmail.org/post/20231115.8713148
Mpox update (47): Congo DR (KU), Malaysia, Indonesia (Jakarta), RFI
http://promedmail.org/post/20231102.8712960
Mpox update (46): Pakistan (KP) ex Saudi Arabia
http://promedmail.org/post/20231102.8712956
Mpox update (45): Viet Nam, fatal, immunocompromised patient
http://promedmail.org/post/20231026.8712826
Mpox update (44): tecovirimat resistance, HIV
http://promedmail.org/post/20231025.8712791
Mpox update (43): worldwide cases, Viet Nam, vaccination
http://promedmail.org/post/20231015.8712649
Mpox update (42): UK, Viet Nam
http://promedmail.org/post/20231009.8712516
Mpox update (41): cases, Vietnam, Congo DR, RFI
http://promedmail.org/post/20230929.8712374
Mpox update (40): worldwide, Congo DR, Laos
http://promedmail.org/post/20230926.8712311
Mpox update (39): cases, China, England, vaccination
http://promedmail.org/post/20230915.8712118
Mpox update (38): Thailand, MSM, teenagers
http://promedmail.org/post/20230904.8711966
Mpox update (37): Pakistan, USA, Congo DR
http://promedmail.org/post/20230901.8711932
Mpox update (36): Malaysia, RFI
http://promedmail.org/post/20230825.8711837
Mpox update (35): Spain, Pakistan
http://promedmail.org/post/20230822.8711787
Mpox update (34): Taiwan, fatal, corr
http://promedmail.org/post/20230815.8711712
Mpox update (34): Taiwan, fatal
http://promedmail.org/post/20230815.8711702
Mpox update (33): China, Australia
http://promedmail.org/post/20230813.8711686
Mpox update (32): Taiwan http://promedmail.org/post/20230810.8711633
Mpox update (31): http://promedmail.org/post/20230805.8711570
Mpox update (30): cases, steroids, Trinidad and Tobago, Pakistan,
Portugal, RFI http://promedmail.org/post/20230801.8711442
Mpox update (29): cases, Congo DR
http://promedmail.org/post/20230724.8711303
Mpox update (28): cases, comment, Trinidad & Tobago, UK, Germany,
comparison http://promedmail.org/post/20230714.8711137
Mpox update (27): cases, Cameroon, Thailand, RFI
http://promedmail.org/post/20230711.8710983
Mpox update (26): cases, USA, Canada, Israel, South Korea
http://promedmail.org/post/20230701.8710843
Mpox update (25): cases, vaccine, China, resurgence
http://promedmail.org/post/20230625.8710712
Mpox update (24): cases, detection, UK, PCR
http://promedmail.org/post/20230622.8710641
Mpox update (23): viral shedding, Beijing, STI, Taiwan
http://promedmail.org/post/20230616.8710543
Mpox update (22): cases, recurrent outbreaks, UK
http://promedmail.org/post/20230611.8710429
Mpox update (21): USA, Cameroon, cases, wastewater
http://promedmail.org/post/20230528.8710251
Mpox update (20): cases, WHO, USA, France
http://promedmail.org/post/20230519.8710125
Mpox update (19): USA, South Korea, Brazil, cases, resurgence, RFI
http://promedmail.org/post/20230513.8709994
Mpox update (18): WHO, Pakistan, USA, sociobehavioral factors
http://promedmail.org/post/20230508.8709908
Mpox update (17): cases, South Korea, Japan, Pakistan, UK
http://promedmail.org/post/20230501.8709757
Mpox update (16): cases, disparities, South Korea
http://promedmail.org/post/20230422.8709604
Mpox update (15): cases, Japan, AIDS-defining
http://promedmail.org/post/20230414.8709457
Mpox update (14): worldwide, USA, Congo DR (HU), vaccination
http://promedmail.org/post/20230409.8709364
Mpox update (13): cases, Netherlands, virtual ward
http://promedmail.org/post/20230402.8709218
Mpox update (12): Japan, TikTok, Jamaica, vaccination
http://promedmail.org/post/20230324.8709105
Mpox update (11): cases, incubation, reinfection, Mexico, Jynneos
http://promedmail.org/post/20230318.8708975
Mpox update (10): Taiwan, undetected case, death, treatment
http://promedmail.org/post/20230311.8708853
Mpox update (09): worldwide, USA, Taiwan, occupational transm,
sampling, immunology http://promedmail.org/post/20230303.8708676
Mpox update (08): worldwide, Belgium
http://promedmail.org/post/20230224.8708552
Mpox update (07): worldwide, USA, WHO, wastewater
http://promedmail.org/post/20230217.8708422
Mpox update (06): worldwide, antivirals
http://promedmail.org/post/20230210.8708259
Mpox update (05): worldwide, USA
http://promedmail.org/post/20230202.8708119
Mpox update (04): worldwide, USA, drug sensitivity, evolution, Viet
Nam http://promedmail.org/post/20230126.8707984
Mpox update (03): worldwide, USA, DR Congo
http://promedmail.org/post/20230120.8707842
Mpox update (02): worldwide, USA, antivirals
http://promedmail.org/post/20230113.8707762
Mpox update (01): worldwide, USA, breakthrough cases, unvaccinated,
women http://promedmail.org/post/20230106.8707651]
.................................................sb/cs/may/jh
*##########################################################*
************************************************************
ProMED makes every effort to verify the reports that are posted, but the ac=
curacy
and completeness of the information, and of any statements or opinions base=
d
thereon, are not guaranteed. The reader assumes all risks in using informat=
ion
posted or archived by ProMED. ISID and its associated service providers sha=
ll not
be held responsible for errors or omissions or held liable for any damages =
incurred
as a result of use or reliance upon posted or archived material.
************************************************************
Donate to ProMED. Details available at: https://isid.networkforgood.com/pro=
jects/79924-invest-in-the-mission.
************************************************************
Visit ProMED's website at https://www.promedmail.org/.
Submit all items for posting via the ProMED website at https://promedmail.o=
rg/submitinfo/.
If you have any questions or need support, please contact us via the ProMED=
 website at  https://promedmail.org/support/.
You may subscribe/unsubscribe at  https://isid.org/promedmail-subscribe/.
Unsubscribe Preferences ( https://u19268662.ct.sendgrid.net/asm/?user_id=3D=
19268662&data=3DcKjuOFmqgjZJHiSBCk_wRu5iwZAEXN7jmpSDLxb_oxhoMDAwdTAwMMUwPqB=
fM271T4gxRQokO3_xQVr4tzztrYHXbYzbqg9R9q-ifFCXOkWjmBfEDkaH2gQBJnWchgThlJsuBk=
yWsiNJkxzCngHDuhjmewCTDOETvl_F8swVMRVgZk_UHEZmKUs2F-jxrYAfPaOO2q57nPyrRmNb5=
2SfPcY98fQhXpts7So-PFOEAI6J9nltR--OK6pFtbMY1esycLopiUzjImVY2l9mSeTQpJbYeJPR=
EW3_ysdeNYN-JKN5W6F6xGhVnRN3hMNecf8UJTgbZvUg_AjtbBZDCvYZBBrMxXYCeJsHCKX7G5s=
tWi5Z-AVg-IKXfyCov2zY5nSF2wolCRUGudQ5b12rTHOEb0i5Fhy3SqwgEyc88d8blu17PACZfy=
m0mKgcOxAmw0scJ0BURWF9ZFxzF72mcqxyV6Dklrt7Db4Lu6u7NY1WHL6QKyNrX8ael-Bn_RoTF=
Wiv48pmTQfIUCI2QoPNE8ro9lXXArtkyvHfXqO3rLgRLJZmsCfBAMFmRdqeiBAwv5LfvvaGRdmo=
OlfBmKpMboWNcKthDDuu0RuGHsL0AucI4KoPKM1axay2rujL91pYFPg_BjXm2wKGKmHa6qDc3vA=
z5oBx7P5nR-0hd4jG6B7Vot68sXZwekzm0CoC9zKxJwzg9-zPiA1r_IBZGZZ3Ezr_mtuJdid0Ub=
tqFaH5L6bPgMeJh6jA2nXh9ETQP2bUSaqyxjbgEbZu4D7_KQCgiMDyseDah6Ye1E0sAuGO4f8nd=
SJnV3odukqI4dL3pML2-Q0i21CgRynIaYxjj3qUHCEvFR1H5cJ2hl91oqNGaxncZGf98MCenA3t=
gGNaXhTgUKcvar46t_3UybDhOIzq1ZV70U5uE9ME4jzw-nf5YnZXu1VINUXYZ_Vmk5W8nxlFfw-=
txxdVbj1U8cZv2RNIH1jNqOUjfaDluhWrj1glpdchOuLM081huUsAY-tSxxdLTcmExTiZaruXi-=
3_rhoSJ2J7dmAaMUwsIPJycfblihH96X5WxzQ7DW48BdeFmzhS9aVMP4ESgbqNdB3-CvZ1WinAM=
bZruFJCFcgmggLo-QzIYtQppt_RsYq_quU_-HrJ4ZEb7Dx1fhaqNgjin0i9mRyep79aIeD0uKm3=
kiyOUE58izUsHHVJaYlsj2PhtIENnnwblWIdfYAk9R3u0y4S9Hqvr_Bsnn8A1Tu0 )
############################################################
############################################################

--7580712b779411cfa2cab9ba516098e8cc63612d7a780e79fdb083b92193
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset=us-ascii
Mime-Version: 1.0

<!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>MPOX UPDATE (03): NIGERIA, ATYPICAL CASES, 2022<br>******************=
*****************************<br>A ProMED-mail post<br><a href=3D"https://u=
19268662.ct.sendgrid.net/ss/c/wscE2ng5fl6JrPIt48tisIijpefK5PNjW-mL-YZGnfgDO=
xU1G3gjwnPSi2Tfv3HA/431/L5f3CG6sThyAAFO2SQEvAQ/h0/O6bbDJnTTSQcpPbbVAHdhKfMd=
--KFm3JAFyxiQg1_Og">http://www.promedmail.org</a><br>ProMED-mail is a progr=
am of the<br>International Society for Infectious Diseases<br><a href=3D"ht=
tps://u19268662.ct.sendgrid.net/ss/c/wscE2ng5fl6JrPIt48tisCT5tpD4Upm3qyMCbc=
YSQvc/431/L5f3CG6sThyAAFO2SQEvAQ/h1/jzN0CV7nenED36BaB-vY5H0ztPjql23R8sgX6bj=
rthE">http://www.isid.org</a><br><br>Date: Sat 13 Jan 2024=0D<br>Source: He=
alio [edited]=0D<br><a href=3D"https://u19268662.ct.sendgrid.net/ss/c/TLh_c=
srC34X_iXpbYoMam6nIJeLKIYln-TR_4o7skbuJ-mO5oWBUMBp3RCxr3BjtgJE9JOC5z7BzT6dK=
W4t9UrCw0O7MuUNmXanKqR_i_SXrSHrHGTkEShljzvBfwPUoTkS8KIE6rQnfEcol60nMUsslRwL=
_zFtyRzo7S6PuIqQ/431/L5f3CG6sThyAAFO2SQEvAQ/h2/b9gcHqDt57SIZ_89tTmWaethW0h4=
oWARq0_dGDW9hGo">https://www.healio.com/news/infectious-disease/20240112/20=
22-mpox-outbreak-cases-had-atypical-symptoms-and-presentation</a>=0D<br>=0D=
<br>=0D<br>During a 2022 mpox outbreak in a Nigerian tertiary care facility=
,<br>several confirmed cases presented atypically, according to a recent<br=
>assessment of cases.=0D<br>=0D<br>"Having managed cases of mpox previously=
, I became amazed at the<br>gradual drift of the clinical presentation from=
 the usual, previously<br>documented, and observed pattern of presentation =
to some forms I<br>considered atypical," Nneka M. Chika-Igwenyi, MD, an inf=
ectious<br>diseases physician at Alex Ekwueme Federal University Teaching<b=
r>Hospital, Abakaliki, told Healio. "This spored me into highlighting<br>so=
me of the observed atypical presentations."=0D<br>=0D<br>During a 2022 mpox=
 outbreak in a Nigerian facility, cases deviated<br>from the typical presen=
tation highlighting the need for further<br>evaluation of unusual skin lesi=
ons and increased mpox screening.<br>Chika-Igwenyi and colleagues assessed =
clinical and epidemiological<br>data of PCR-confirmed mpox cases reported d=
uring the 2022 outbreak to<br>gather information on unusual presentations.=0D=
<br>=0D<br>Of 17 suspected cases reported during the outbreak, 13 were PCR<=
br>confirmed. Among these 13 patients, there were several atypical<br>prese=
ntations.=0D<br>=0D<br>According to Chika-Igwenyi, these cases occurred amo=
ng young adults<br>and were more common in males (64.3%), which is in contr=
ast to<br>previously documented occurrence in children and young females.<b=
r>Additionally, among these patients, there was a lack of prodromal<br>symp=
toms (reported among only 3 or 23.1% of cases) that usually<br>indicate the=
 onset of skin lesions. When patients did have prodromal<br>symptoms, sympt=
oms persisted for longer than a week in 38.5% of<br>cases.=0D<br>=0D<br>All=
 13 patients experienced rash of "various distribution." Skin<br>lesions we=
re polymorphic in 6 cases (46.2%) with solitary skin lesions<br>reported in=
 3 patients (23.1%). Chika-Igwenyi added that contrary to<br>previous outbr=
eaks where skin lesions followed typical stages and were<br>synchronous, so=
me cases had asynchronous lesions with rashes occurring<br>at different sta=
ges of development. According to the study,<br>significant genital lesions =
were reported in both genders and in 6<br>(46.2%) cases. Perianal lesions w=
ere also reported atypically among<br>heterosexuals and non-men who have se=
x with men population patients<br>(71.1%) with one case (7.7%) being severe=
.=0D<br>=0D<br>Based on these assessments, Chika-Igwenyi said that moving f=
orward<br>there needs to be screening and evaluation of genital skin lesion=
s<br>presumed to be sexually transmitted infections. There should also be a=
<br>revision of clinical case definition to include the reported atypical<b=
r>presentations.=0D<br>=0D<br>"[There should be a] high index of suspicion =
among clinicians and<br>public health interventions using a one-health appr=
oach,"<br>Chika-Igwenyi concluded.=0D<br>=0D<br>[Byline: Caitlyn Stulpin]=0D=
<br>=0D<br>--=0D<br>Communicated by:=0D<br>ProMED<br><br>[This case report =
highlights the need for further inclusion of mpox in<br>clinician different=
ials for patients with any genital lesion<br>regardless of sex or sexuality=
. As we have seen throughout mpox<br>outbreaks, case presentation can be ex=
tremely variable with symptoms<br>typically residing on their own. This sho=
uld raise concern as to<br>whether patients are actually receiving the appr=
opriate diagnosis or<br>if the virus is simply running its course. The prod=
romal phase they<br>present with also means that patients could be contagio=
us for an<br>extended period without rash symptoms, leading to further spre=
ad of<br>the virus. - Mod.CS<br><br>ProMED map:<br>Nigeria: <a href=3D"http=
s://u19268662.ct.sendgrid.net/ss/c/sSnCkKCWBvais3EuVAOvgy2WOIX7pp1nXnn4Abwu=
Q3Z6WbkfhqXYXU-aTMPJ8yThV5qy4ybRtblf0UOPZ1ofzA/431/L5f3CG6sThyAAFO2SQEvAQ/h=
3/sr1R5VlRwfoDXJyhIM-5gl_MscfVV9XglJTZu1nC31k">https://promedmail.org/prome=
d-post?place=3D8714253,62</a>]<br><br>[See Also:<br>Mpox update (02): Israe=
l, new cases, MOH<br>http://promedmail.org/post/20240111.8714172=0D<br>Mpox=
 update (01): Cambodia, new cases<br>http://promedmail.org/post/20240105.87=
14076=0D<br>2023=0D<br>----=0D<br>Mpox update (51): Cambodia (PP) local cas=
e<br>http://promedmail.org/post/20231214.8713728=0D<br>Mpox update (50): Vi=
et Nam (Mekong Delta region)<br>http://promedmail.org/post/20231208.8713590=0D=
<br>Mpox update (49): WHO, Congo DR, USA (ID), Indonesia<br>http://promedma=
il.org/post/20231127.8713353=0D<br>Mpox update (48): Viet Nam, Taiwan, Indo=
nesia<br>http://promedmail.org/post/20231115.8713148=0D<br>Mpox update (47)=
: Congo DR (KU), Malaysia, Indonesia (Jakarta), RFI<br>http://promedmail.or=
g/post/20231102.8712960=0D<br>Mpox update (46): Pakistan (KP) ex Saudi Arab=
ia<br>http://promedmail.org/post/20231102.8712956=0D<br>Mpox update (45): V=
iet Nam, fatal, immunocompromised patient<br>http://promedmail.org/post/202=
31026.8712826=0D<br>Mpox update (44): tecovirimat resistance, HIV<br>http:/=
/promedmail.org/post/20231025.8712791=0D<br>Mpox update (43): worldwide cas=
es, Viet Nam, vaccination<br>http://promedmail.org/post/20231015.8712649=0D=
<br>Mpox update (42): UK, Viet Nam<br>http://promedmail.org/post/20231009.8=
712516=0D<br>Mpox update (41): cases, Vietnam, Congo DR, RFI<br>http://prom=
edmail.org/post/20230929.8712374=0D<br>Mpox update (40): worldwide, Congo D=
R, Laos<br>http://promedmail.org/post/20230926.8712311=0D<br>Mpox update (3=
9): cases, China, England, vaccination<br>http://promedmail.org/post/202309=
15.8712118=0D<br>Mpox update (38): Thailand, MSM, teenagers<br>http://prome=
dmail.org/post/20230904.8711966=0D<br>Mpox update (37): Pakistan, USA, Cong=
o DR<br>http://promedmail.org/post/20230901.8711932=0D<br>Mpox update (36):=
 Malaysia, RFI<br>http://promedmail.org/post/20230825.8711837=0D<br>Mpox up=
date (35): Spain, Pakistan<br>http://promedmail.org/post/20230822.8711787=0D=
<br>Mpox update (34): Taiwan, fatal, corr<br>http://promedmail.org/post/202=
30815.8711712=0D<br>Mpox update (34): Taiwan, fatal<br>http://promedmail.or=
g/post/20230815.8711702=0D<br>Mpox update (33): China, Australia<br>http://=
promedmail.org/post/20230813.8711686=0D<br>Mpox update (32): Taiwan http://=
promedmail.org/post/20230810.8711633=0D<br>Mpox update (31): http://promedm=
ail.org/post/20230805.8711570=0D<br>Mpox update (30): cases, steroids, Trin=
idad and Tobago, Pakistan,<br>Portugal, RFI http://promedmail.org/post/2023=
0801.8711442=0D<br>Mpox update (29): cases, Congo DR<br>http://promedmail.o=
rg/post/20230724.8711303=0D<br>Mpox update (28): cases, comment, Trinidad &=
 Tobago, UK, Germany,<br>comparison http://promedmail.org/post/20230714.871=
1137=0D<br>Mpox update (27): cases, Cameroon, Thailand, RFI<br>http://prome=
dmail.org/post/20230711.8710983=0D<br>Mpox update (26): cases, USA, Canada,=
 Israel, South Korea<br>http://promedmail.org/post/20230701.8710843=0D<br>M=
pox update (25): cases, vaccine, China, resurgence<br>http://promedmail.org=
/post/20230625.8710712=0D<br>Mpox update (24): cases, detection, UK, PCR<br=
>http://promedmail.org/post/20230622.8710641=0D<br>Mpox update (23): viral =
shedding, Beijing, STI, Taiwan<br>http://promedmail.org/post/20230616.87105=
43=0D<br>Mpox update (22): cases, recurrent outbreaks, UK<br>http://promedm=
ail.org/post/20230611.8710429=0D<br>Mpox update (21): USA, Cameroon, cases,=
 wastewater<br>http://promedmail.org/post/20230528.8710251=0D<br>Mpox updat=
e (20): cases, WHO, USA, France<br>http://promedmail.org/post/20230519.8710=
125=0D<br>Mpox update (19): USA, South Korea, Brazil, cases, resurgence, RF=
I<br>http://promedmail.org/post/20230513.8709994=0D<br>Mpox update (18): WH=
O, Pakistan, USA, sociobehavioral factors<br>http://promedmail.org/post/202=
30508.8709908=0D<br>Mpox update (17): cases, South Korea, Japan, Pakistan, =
UK<br>http://promedmail.org/post/20230501.8709757=0D<br>Mpox update (16): c=
ases, disparities, South Korea<br>http://promedmail.org/post/20230422.87096=
04=0D<br>Mpox update (15): cases, Japan, AIDS-defining<br>http://promedmail=
.org/post/20230414.8709457=0D<br>Mpox update (14): worldwide, USA, Congo DR=
 (HU), vaccination<br>http://promedmail.org/post/20230409.8709364=0D<br>Mpo=
x update (13): cases, Netherlands, virtual ward<br>http://promedmail.org/po=
st/20230402.8709218=0D<br>Mpox update (12): Japan, TikTok, Jamaica, vaccina=
tion<br>http://promedmail.org/post/20230324.8709105=0D<br>Mpox update (11):=
 cases, incubation, reinfection, Mexico, Jynneos<br>http://promedmail.org/p=
ost/20230318.8708975=0D<br>Mpox update (10): Taiwan, undetected case, death=
, treatment<br>http://promedmail.org/post/20230311.8708853=0D<br>Mpox updat=
e (09): worldwide, USA, Taiwan, occupational transm,<br>sampling, immunolog=
y http://promedmail.org/post/20230303.8708676=0D<br>Mpox update (08): world=
wide, Belgium<br>http://promedmail.org/post/20230224.8708552=0D<br>Mpox upd=
ate (07): worldwide, USA, WHO, wastewater<br>http://promedmail.org/post/202=
30217.8708422=0D<br>Mpox update (06): worldwide, antivirals<br>http://prome=
dmail.org/post/20230210.8708259=0D<br>Mpox update (05): worldwide, USA<br>h=
ttp://promedmail.org/post/20230202.8708119=0D<br>Mpox update (04): worldwid=
e, USA, drug sensitivity, evolution, Viet<br>Nam http://promedmail.org/post=
/20230126.8707984=0D<br>Mpox update (03): worldwide, USA, DR Congo<br>http:=
//promedmail.org/post/20230120.8707842=0D<br>Mpox update (02): worldwide, U=
SA, antivirals<br>http://promedmail.org/post/20230113.8707762=0D<br>Mpox up=
date (01): worldwide, USA, breakthrough cases, unvaccinated,<br>women http:=
//promedmail.org/post/20230106.8707651]<br>................................=
.................sb/cs/may/jh<br></body>
</html><!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>*##########################################################*<br>*****=
*******************************************************<br>ProMED makes eve=
ry effort to verify the reports that are posted, but the accuracy<br>and co=
mpleteness of the information, and of any statements or opinions based<br>t=
hereon, are not guaranteed. The reader assumes all risks in using informati=
on<br>posted or archived by ProMED. ISID and its associated service provide=
rs shall not<br>be held responsible for errors or omissions or held liable =
for any damages incurred<br>as a result of use or reliance upon posted or a=
rchived material.<br>******************************************************=
******<br>Donate to ProMED. Details available at: https://isid.networkforgo=
od.com/projects/79924-invest-in-the-mission.<br>***************************=
*********************************<br>Visit ProMED's website at https://www.=
promedmail.org/.<br>Submit all items for posting via the ProMED website at =
https://promedmail.org/submitinfo/.<br>If you have any questions or need su=
pport, please contact us via the ProMED website at  https://promedmail.org/=
support/.<br>You may subscribe/unsubscribe at  https://isid.org/promedmail-=
subscribe/.<br><div><a href=3D"https://u19268662.ct.sendgrid.net/asm/?user_=
id=3D19268662&amp;data=3DcKjuOFmqgjZJHiSBCk_wRu5iwZAEXN7jmpSDLxb_oxhoMDAwdT=
AwMMUwPqBfM271T4gxRQokO3_xQVr4tzztrYHXbYzbqg9R9q-ifFCXOkWjmBfEDkaH2gQBJnWch=
gThlJsuBkyWsiNJkxzCngHDuhjmewCTDOETvl_F8swVMRVgZk_UHEZmKUs2F-jxrYAfPaOO2q57=
nPyrRmNb52SfPcY98fQhXpts7So-PFOEAI6J9nltR--OK6pFtbMY1esycLopiUzjImVY2l9mSeT=
QpJbYeJPREW3_ysdeNYN-JKN5W6F6xGhVnRN3hMNecf8UJTgbZvUg_AjtbBZDCvYZBBrMxXYCeJ=
sHCKX7G5stWi5Z-AVg-IKXfyCov2zY5nSF2wolCRUGudQ5b12rTHOEb0i5Fhy3SqwgEyc88d8bl=
u17PACZfym0mKgcOxAmw0scJ0BURWF9ZFxzF72mcqxyV6Dklrt7Db4Lu6u7NY1WHL6QKyNrX8ae=
l-Bn_RoTFWiv48pmTQfIUCI2QoPNE8ro9lXXArtkyvHfXqO3rLgRLJZmsCfBAMFmRdqeiBAwv5L=
fvvaGRdmoOlfBmKpMboWNcKthDDuu0RuGHsL0AucI4KoPKM1axay2rujL91pYFPg_BjXm2wKGKm=
Ha6qDc3vAz5oBx7P5nR-0hd4jG6B7Vot68sXZwekzm0CoC9zKxJwzg9-zPiA1r_IBZGZZ3Ezr_m=
tuJdid0UbtqFaH5L6bPgMeJh6jA2nXh9ETQP2bUSaqyxjbgEbZu4D7_KQCgiMDyseDah6Ye1E0s=
AuGO4f8ndSJnV3odukqI4dL3pML2-Q0i21CgRynIaYxjj3qUHCEvFR1H5cJ2hl91oqNGaxncZGf=
98MCenA3tgGNaXhTgUKcvar46t_3UybDhOIzq1ZV70U5uE9ME4jzw-nf5YnZXu1VINUXYZ_Vmk5=
W8nxlFfw-txxdVbj1U8cZv2RNIH1jNqOUjfaDluhWrj1glpdchOuLM081huUsAY-tSxxdLTcmEx=
TiZaruXi-3_rhoSJ2J7dmAaMUwsIPJycfblihH96X5WxzQ7DW48BdeFmzhS9aVMP4ESgbqNdB3-=
CvZ1WinAMbZruFJCFcgmggLo-QzIYtQppt_RsYq_quU_-HrJ4ZEb7Dx1fhaqNgjin0i9mRyep79=
aIeD0uKm3kiyOUE58izUsHHVJaYlsj2PhtIENnnwblWIdfYAk9R3u0y4S9Hqvr_Bsnn8A1Tu0" =
target=3D"_blank" class=3D"Unsubscribe--unsubscribePreferences" style=3D"fo=
nt-family:sans-serif;text-decoration:none;">Unsubscribe Preferences</a></di=
v><br>############################################################<br>#####=
#######################################################<br><br><img src=3D"=
https://u19268662.ct.sendgrid.net/ss/o/LbtalBvHhFtzyiegKfBhew/431/L5f3CG6sT=
hyAAFO2SQEvAQ/ho.gif" alt=3D"" width=3D"1" height=3D"1" border=3D"0" style=
=3D"height:1px !important;width:1px !important;border-width:0 !important;ma=
rgin-top:0 !important;margin-bottom:0 !important;margin-right:0 !important;=
margin-left:0 !important;padding-top:0 !important;padding-bottom:0 !importa=
nt;padding-right:0 !important;padding-left:0 !important;"/></body>
</html>
--7580712b779411cfa2cab9ba516098e8cc63612d7a780e79fdb083b92193--
